Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology. 2003;42(Suppl 2):11–6. https://doi.org/10.1093/rheumatology/keg327.

Article  CAS  Google Scholar 

Novack DV, Teitelbaum SL. The osteoclast: friend or foe? Annu Rev Pathol. 2008;3(457–4):84 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%26;db=PubMed%26;dopt=Citation%26;list_uids=18039135.

Google Scholar 

Sato K, Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol. 2006;18(4):419–26. https://doi.org/10.1097/01.bor.0000231912.24740.a5.

Article  CAS  PubMed  Google Scholar 

Boyce BF, et al. New roles for osteoclasts in bone. Ann N Y Acad Sci. 2007;1116:245–54 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%26;db=PubMed%26;dopt=Citation%26;list_uids=18083932.

Article  CAS  PubMed  Google Scholar 

Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8(11):656–64 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%26;db=PubMed%26;dopt=Citation%26;list_uids=23007741.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teitelbaum SL. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther. 2006;8(1):201 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%26;db=PubMed%26;dopt=Citation%26;list_uids=16356195.

Article  PubMed  Google Scholar 

Choi Y, Arron JR, Townsend MJ. Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10):543–8. https://doi.org/10.1038/nrrheum.2009.175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Veis DJ, O’Brien CA. Osteoclasts, master sculptors of bone. Annu Rev Pathol. 2023;18:257–81. https://doi.org/10.1146/annurev-pathmechdis-031521-040919.

Article  CAS  PubMed  Google Scholar 

Novack DV, Mbalaviele G. Osteoclasts-key players in skeletal health and disease. Microbiol Spectr. 2016. https://doi.org/10.1128/microbiolspec.MCHD-0011-2015.

Article  PubMed  Google Scholar 

Boyce BF, Rosenberg E, de Papp AE, Duong LT. The osteoclast, bone remodelling and treatment of metabolic bone disease. Eur J Clin Invest. 2012;42(12):1332–41. https://doi.org/10.1111/j.1365-2362.2012.02717.x.

Article  CAS  PubMed  Google Scholar 

Aspenberg P. Denosumab and atypical femoral fractures. Acta Orthop. 2014;85(1):1. https://doi.org/10.3109/17453674.2013.859423.

Article  PubMed  PubMed Central  Google Scholar 

Boquete-Castro A, Gomez-Moreno G, Calvo-Guirado JL, Aguilar-Salvatierra A, Delgado-Ruiz RA. Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials. Clin Oral Implants Res. 2016;27(3):367–75. https://doi.org/10.1111/clr.12556.

Article  PubMed  Google Scholar 

Popp AW, Zysset PK, Lippuner K. Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics. Osteoporos Int. 2016;27(5):1917–21. https://doi.org/10.1007/s00198-015-3458-6.

Article  CAS  PubMed  Google Scholar 

Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12(1):49–62. https://doi.org/10.1038/nrrheum.2015.169.

Article  CAS  PubMed  Google Scholar 

Hicks MR, Pyle AD. The emergence of the stem cell niche. Trends Cell Biol. 2023;33(2):112–23. https://doi.org/10.1016/j.tcb.2022.07.003.

Article  PubMed  Google Scholar 

Calvi LM, Link DC. The hematopoietic stem cell niche in homeostasis and disease. Blood. 2015;126(22):2443–51. https://doi.org/10.1182/blood-2015-07-533588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takahashi N, et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 1988;123(5):2600–2. https://doi.org/10.1210/endo-123-5-2600.

Article  CAS  PubMed  Google Scholar 

Udagawa N, et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 1989;125(4):1805–13. https://doi.org/10.1210/endo-125-4-1805.

Article  CAS  PubMed  Google Scholar 

Otsuka E, Notoya M, Hagiwara H. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int. 2003;73(1):72–7. https://doi.org/10.1007/s00223-002-1071-0.

Article  CAS  PubMed  Google Scholar 

Ghosh-Choudhury N, et al. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression. J Biol Chem. 2006;281(29):20160–70. https://doi.org/10.1074/jbc.M511071200.

Article  CAS  PubMed  Google Scholar 

Thomas GP, Baker SU, Eisman JA, Gardiner EM. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol. Aug2001;170(2):451–60. https://doi.org/10.1677/joe.0.1700451.

Article  CAS  PubMed  Google Scholar 

Huang JC, et al. Pth differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004;19(2):235–44. https://doi.org/10.1359/JBMR.0301226.

Article  CAS  PubMed  Google Scholar 

Xiong J, O’Brien CA. Osteocyte RANKL: new insights into the control of bone remodeling. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2012;27(3):499–505. https://doi.org/10.1002/jbmr.1547.

Article  CAS  PubMed  Google Scholar 

Elford PR, Felix R, Cecchini M, Trechsel U, Fleisch H. Murine osteoblastlike cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture. Calcif Tissue Int. 1987;41(3):151–6. https://doi.org/10.1007/BF02563795.

Article  CAS  PubMed  Google Scholar 

Tanaka S, et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 1993;91(1):257–63. https://doi.org/10.1172/JCI116179.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakashima T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17(10):1231–4. https://doi.org/10.1038/nm.2452.

Article  CAS  PubMed  Google Scholar 

Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’Brien Charles A. Matrix-embedded cells control osteoclast formation. Nat Med. 2011;17(10):1235–41. https://doi.org/10.1038/nm.2448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Werner SL, et al. Csf-1 in osteocytes inhibits Nox4-mediated oxidative stress and promotes normal bone homeostasis. JBMR Plus. 2020;4:e10080. https://doi.org/10.1002/jbm4.10080.

Article  CAS  PubMed  Google Scholar 

El-Masri BM, et al. Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res. 2024;12(1):62. https://doi.org/10.1038/s41413-024-00362-4.

Article  CAS  PubMed